Trial Search Results
Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias
This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.
Stanford is currently accepting patients for this trial.
- Device: Ambulatory ECG
1. Possession of the following at time of eligibility screening:
- iPhone (5s or later) with iOS version 12.1.1 or later defined as iPhone model/iOS
version used to complete screening eligibility.
- Apple Watch (Series 1-4) with watchOS version 5.1.2 or later defined as Apple
Watch model/watchOS paired with iPhone used to complete screening eligibility
2. At least one of the following by self-report before consent:
- Irregular Rhythm Notification
- ECG app classification of Atrial Fibrillation
- ECG app classification of Inconclusive defined as "Inconclusive," "Heart Rate
Over 120," or "Heart Rate Under 50"
3. Age ≥ 22 years at time of eligibility screening
4. Current resident of the United States at time of eligibility screening, and will
reside in the United States for the length of the study
5. Proficient in written and spoken English
6. Valid phone number associated with iPhone, ascertained from self-report
7. Valid email address, ascertained from self-report
1. Shared iCloud account
2. Shared AppleWatch
Ages Eligible for Study
22 Years - N/A
Genders Eligible for Study